Physician profile
Afu Mohammad Abdul
NPI 1285834838
$1,748.62
in general payments reported to CMS, 2019-2025
20 companies · $24.78 in 2025
The $24.78 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $53.65 · 2021: $57.13 · 2022: $335 · 2023: $756 · 2024: $302 · 2025: $24.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Education: $68.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.56 |
| Education | $68.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $382.57 | 2019-2024 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $225.68 | 2022-2024 | |
| Fresenius USA Marketing, INC. | $178.02 | 2022-2024 | Velphoro |
| Horizon Therapeutics Plc | $141.11 | 2019-2023 | Krystexxa |
| Calliditas Therapeutics US INC. | $139.63 | 2023-2024 | Tarpeyo |
| Otsuka America Pharmaceutical, INC. | $133.07 | 2019-2023 | Jynarque |
| Akebia Therapeutics INC | $114.18 | 2021-2024 | Vafseo |
| Travere Therapeutics, INC. | $66.82 | 2019-2023 | |
| Vifor Pharma, INC. | $56.23 | 2022-2024 | Veltassa, Korsuva |
| Glaxosmithkline, LLC. | $50.77 | 2022-2023 | Benlysta |
| Aurinia Pharma U.S., INC. | $39.38 | 2022-2023 | Lupkynis |
| Kyowa Kirin, INC. | $35.59 | 2024 | Crysvita |
| Amgen INC. | $33.21 | 2020-2023 | Tavneos |
| Pfizer INC. | $29.42 | 2024 | |
| Nxstage Medical, INC. | $24.78 | 2025 | Liberty Select Cycler |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.88 | 2022 | |
| Ani Pharmaceuticals, INC. | $20.36 | 2023 | Purified Cortrophin Gel |
| Lilly USA, LLC | $19.37 | 2024 | Jardiance |
| Abbott Laboratories | $19.25 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.30 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afu Abdul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.